
Cambiar Pharma Private Limited
About Cambiar Pharma Private Limited
Data last updated:
Cambiar Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC113978. Its GSTIN is 36AAGCC8012R1Z8 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kothawar Sunil Kumar and Boora Sunil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017.
As per the financials filed for FY 2023, the company reported a revenue of ₹9.2 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹7,270 (net margin -0.8%) and EBITDA of -₹4,095 (EBITDA margin -0.4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cambiar Pharma Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cambiar Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cambiar Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cambiar Pharma Private Limited, buy the company report.
Financials of Cambiar Pharma Private Limited
FY 2025 filings availableCambiar Pharma Private Limited reported revenue of ₹9.2 Lakh (up 20% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹9.2 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4,095 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,270 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cambiar Pharma Private Limited, buy the company report.
Board of directors of Cambiar Pharma Private Limited
Cambiar Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kothawar Sunil Kumar | Director | 23 Jan 2017 | 9 Years 8 Months | Current |
| Boora Sunil Kumar Also directs: Harihara Kumar Associates LLP, Aurum Quest Infra Ventures LLP | Director | 10 Jan 2017 | 9 Years 9 Months | Current |
Auditor
Cambiar Pharma Private Limited is audited by PRODDUTURVIJAYABHASKER for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRODDUTURVIJAYABHASKER | FY 2023 | 250663 |
Shareholding
The shareholding of Cambiar Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cambiar Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cambiar Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cambiar Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cambiar Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC8012R1Z8 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cambiar Pharma Private Limited, buy the company report.
Recent activity
Cambiar Pharma Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Kothawar Sunil Kumar ceased to be Additional Director on 29 Sep 2017.
Frequently asked questions
Cambiar Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 2017 (9+ years old) and is registered under CIN U24304TG2017PTC113978.
Cambiar Pharma has 2 current directors:
- Kothawar Sunil Kumar - Director
- Boora Sunil Kumar - Director
The latest financial statements of Cambiar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Cambiar Pharma is 36AAGCC8012R1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Cambiar Pharma is U24304TG2017PTC113978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cambiar Pharma was incorporated on 10 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kothawar Sunil Kumar ceased to be Additional Director on 29 Sep 2017. Dhage Madhusudan ceased to be Additional Director on 27 Jun 2017. Muvva Srikanth ceased to be Director on 27 Jun 2017. Cambiar Pharma has 5 board changes on record in total.
The registered office of Cambiar Pharma is at 05 1st Floor Mehtab Arcade Tarnaka Cross Roads Opp: Ganesh Temple, Secunderabad, Telangana, India – 500017.
Cambiar Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Cambiar Pharma is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.